Skip to main content

Altamira Therapeutics Ltd.

CYTOF
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001601936

No open-market purchases or sales by Altamira Therapeutics Ltd. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.

13F holders, Q3 2023

Institutional positions in Altamira Therapeutics Ltd. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
9
+3 vs. Q2 2023
Shares held
889.3K
+815.5K (+1,105.5%) vs. Q2 2023
Total value
$217.2K
+$170.0K (+359.5%) vs. Q2 2023
New holders
3
0 more added
Sold out
0
1 more reduced

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CYTOF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 9 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 17 institutionsQ4 2021: 19 institutionsQ1 2022: 18 institutionsQ2 2022: 14 institutionsQ3 2022: 15 institutionsQ4 2022: 7 institutionsQ1 2023: 7 institutionsQ2 2023: 6 institutionsQ3 2023: 9 institutionsQ4 2023: 4 institutionsQ1 2024: 3 institutionsQ2 2024: 4 institutionsQ3 2024: 5 institutionsQ4 2024: 2 institutionsQ1 2025: 1 institutionQ2 2025: 1 institutionQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ3 2023: $217.2K
Q1 2021: $0Q2 2021: $0Q3 2021: $1.34MQ4 2021: $1.03MQ1 2022: $607.0KQ2 2022: $142.0KQ3 2022: $119.0KQ4 2022: $34.5KQ1 2023: $7.26KQ2 2023: $47.3KQ3 2023: $217.2KQ4 2023: $26.7KQ1 2024: $3.47KQ2 2024: $2.95KQ3 2024: $71.3KQ4 2024: $1.21KQ1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding CYTOF and their total value by quarter
QuarterHoldersValue
Q2 20261$0
Q1 20261$0
Q4 20251$0
Q3 20251$0
Q2 20251$0
Q1 20251$0
Q4 20242$1.21K
Q3 20245$71.3K
Q2 20244$2.95K
Q1 20243$3.47K
Q4 20234$26.7K
Q3 20239$217.2K
Q2 20236$47.3K
Q1 20237$7.26K
Q4 20227$34.5K
Q3 202215$119.0K
Q2 202214$142.0K
Q1 202218$607.0K
Q4 202119$1.03M
Q3 202117$1.34M
Q2 20210$0
Q1 20210$0

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Altamira Therapeutics Ltd.; share changes are against Q2 2023.

Institutions holding CYTOF in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Armistice Capital, LLC829,000$202.7K0.01%+829,000New
Citadel Advisors LLC39,165$9.45K0.00%−33,766−46.3%Reduced
Susquehanna International Group, LLP10,185$2.46K0.00%+10,185New
XTX Topco Ltd10,131$2.44K0.00%+10,131New
Morgan Stanley500$1220.00%00.0%Unchanged
Group One Trading, L.P.298$720.00%00.0%Unchanged
Wells Fargo & Company25$60.00%00.0%Unchanged
Stonebridge Capital Advisors LLC5$10.00%00.0%Unchanged
Cutler Group LP10$00.00%00.0%Unchanged